Intuitive Surgical, Inc. (NASDAQ:ISRG) CFO Sells $145,840.50 in Stock

Intuitive Surgical, Inc. (NASDAQ:ISRG) CFO Jamie Samath sold 270 shares of the stock in a transaction dated Tuesday, December 10th. The stock was sold at an average price of $540.15, for a total transaction of $145,840.50. Following the transaction, the chief financial officer now directly owns 8,757 shares in the company, valued at $4,730,093.55. The trade was a 2.99 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available at this link.

Jamie Samath also recently made the following trade(s):

• On Friday, November 29th, Jamie Samath sold 188 shares of Intuitive Surgical stock. The shares were sold at an average price of $539.00, for a total value of $101,332.00.
• On Tuesday, November 26th, Jamie Samath sold 108 shares of Intuitive Surgical stock. The shares were sold at an average price of $542.06, for a total value of $58,542.48.
• On Friday, November 8th, Jamie Samath sold 22,903 shares of Intuitive Surgical stock. The stock was sold at an average price of $525.00, for a total value of $12,024,075.00.
• On Monday, November 11th, Jamie Samath sold 269 shares of Intuitive Surgical stock. The stock was sold at an average price of $539.89, for a total transaction of $145,230.41.

Intuitive Surgical Price Performance

NASDAQ ISRG opened at $539.58 on Friday. The firm has a market capitalization of $192.19 billion, a PE ratio of 86.75, a P/E/G ratio of 5.35 and a beta of 1.38. Intuitive Surgical, Inc. has a 12 month low of $320.26 and a 12 month high of $556.23. The company’s 50 day simple moving average is $521.82 and its 200 day simple moving average is $478.46.

Intuitive Surgical (NASDAQ:ISRG) last issued its quarterly earnings results on Thursday, October 17th. The medical equipment provider reported $1.56 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.24 by $0.32. The company had revenue of $2.04 billion for the quarter, compared to analysts’ expectations of $2.01 billion. Intuitive Surgical had a return on equity of 13.41% and a net margin of 28.51%. Sell-side analysts anticipate that Intuitive Surgical, Inc. will post 5.45 earnings per share for the current fiscal year.

Analysts Set New Price Targets

Several research analysts have recently commented on ISRG shares. Erste Group Bank raised shares of Intuitive Surgical from a “hold” rating to a “buy” rating in a report on Tuesday, November 19th. Robert W. Baird lifted their target price on Intuitive Surgical from $503.00 to $565.00 and gave the company an “outperform” rating in a research note on Thursday, October 17th. Truist Financial raised their price target on Intuitive Surgical from $520.00 to $570.00 and gave the stock a “buy” rating in a report on Monday, October 14th. Raymond James upped their price objective on Intuitive Surgical from $500.00 to $540.00 and gave the stock an “outperform” rating in a research note on Monday, October 14th. Finally, JPMorgan Chase & Co. raised their target price on Intuitive Surgical from $495.00 to $575.00 and gave the company an “overweight” rating in a research note on Friday, October 11th. One investment analyst has rated the stock with a sell rating, four have assigned a hold rating and fifteen have assigned a buy rating to the company’s stock. According to data from MarketBeat.com, Intuitive Surgical presently has a consensus rating of “Moderate Buy” and an average target price of $550.28.

Institutional Investors Weigh In On Intuitive Surgical

A number of institutional investors and hedge funds have recently bought and sold shares of the business. Ridgewood Investments LLC acquired a new position in shares of Intuitive Surgical in the 2nd quarter worth approximately $26,000. Godsey & Gibb Inc. grew its position in Intuitive Surgical by 140.0% in the third quarter. Godsey & Gibb Inc. now owns 60 shares of the medical equipment provider’s stock worth $29,000 after buying an additional 35 shares during the last quarter. LGT Financial Advisors LLC increased its holdings in shares of Intuitive Surgical by 415.4% in the second quarter. LGT Financial Advisors LLC now owns 67 shares of the medical equipment provider’s stock valued at $30,000 after buying an additional 54 shares in the last quarter. MidAtlantic Capital Management Inc. acquired a new stake in shares of Intuitive Surgical during the 3rd quarter valued at $33,000. Finally, Mark Sheptoff Financial Planning LLC bought a new stake in shares of Intuitive Surgical during the 2nd quarter worth $37,000. 83.64% of the stock is owned by institutional investors and hedge funds.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.